Gabriele Nicolini

Gabriele Nicolini's work experience begins in 1999 as a sales representative at Chiesi Italia. Gabriele later worked at Faustfarm S.p.A as a Technical Director for a short period. Gabriele then returned to Chiesi Italia, where they held various roles such as Trainer of the sales force, Medical Advisor, and Medical Manager. In 2013, they joined Chiesi Group, where they served as Head of International and Late Phase Studies, Head of Emerging Countries and Phase IV Studies, Global Medical Affairs Head, and Head of Global Medical Affairs & Patient Advocacy. It was also mentioned that they worked as a Global Medical Affairs Leader for an unknown company from June 2022 to October 2022. Finally, they moved on to become a Medical Director at both PIAM Farmaceutici S.p.A. and Bruschettini Farmaceutici in 2022.

Gabriele Nicolini completed their education with a PhD in Experimental Respiratory Pathophysiology from the Università degli Studi di Parma. Gabriele obtained this degree between 2007 and 2009. Prior to that, in 1997, they received a professional abilitation as a pharmacist from the Università degli Studi di Urbino Carlo Bo. Gabriele had completed a Laurea in Farmacia from the Università degli Studi di Milano between 1990 and 1997. Additionally, Gabriele Nicolini obtained a certification for pharmacist professional abilitation from the Università degli Studi di Urbino 'Carlo Bo'. The specific time and year of obtaining this certification are not provided.